R. Ramelmeier
Technik-/Wissenschafts-/F&E-Leiter bei ADVERUM BIOTECHNOLOGIES, INC.
Vermögen: 49 677 $ am 31.05.2024
Profil
R.
Andrew Ramelmeier is currently the Chief Technology Officer at Adverum Biotechnologies, Inc. He previously held positions as the Executive Director-Pharmaceutical Development at Centocor, Inc. from 2001 to 2005, Vice President-Process Sciences at Johnson & Johnson, VP-Manufacturing, Process Sciences & Facilities at BioMarin Pharmaceutical, Inc. from 2006 to 2014, Senior Vice President-Technical Operations at Portola Pharmaceuticals LLC from 2014 to 2017, and Chief Manufacturing & Quality Officer, Senior VP at Sangamo Therapeutics, Inc. from 2018 to 2023.
He obtained his undergraduate degree from The Johns Hopkins University in 1984 and his doctorate degree from the University of California, Berkeley in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.05.2023 | 88 080 ( 0,04% ) | 49 677 $ | 31.05.2024 |
Aktive Positionen von R. Ramelmeier
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.08.2023 |
Ehemalige bekannte Positionen von R. Ramelmeier
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.07.2023 |
| PORTOLA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.01.2014 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | 01.01.2005 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Ausbildung von R. Ramelmeier
| University of California, Berkeley | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
